Global Poultry Vaccine Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Disease Type (Avian Influenza, Marek’s Disease, Bronchitis, Others), By Product (Inactivated Vaccines, Attentuated Live Vaccines, Recombinant Vaccines, Others), And By Geography - Forecasts From 2020 To 2025

Published:  Jan 2021 Report Code: KSI061613992 Pages: 120

The global poultry vaccine market was valued at US$2,129.134 million in 2019. The growth of this market is primarily attributed to the rapidly growing poultry production across the globe coupled with the growing incidence of a number of diseases among poultry. According to the United Nations Food and Agriculture Organization (UN FAO), poultry meat production was forecasted to increase by 3 percent in 2019 from 125 million metric tons in 2018. In Europe, between February 16, 2019, and August 15, 2019, two low pathogenic avian influenzas (LPAI) A(H5N1) outbreaks along with one LPAI A(H7N7) outbreak in poultry in Denmark and one LPAI A(H7N3) outbreak in poultry in Italy were reported. As people are consuming more poultry-related food products, rising awareness about the harmful impact of the consumption of diseased poultry food products on human health is further pressurizing poultry manufacturers to vaccinate their poultry on a regular basis, thus positively impacting the global poultry vaccine market growth. Governments and global organizations are also taking initiatives to create more awareness about animal health and goof animal husbandry practices. Increasing poultry healthcare expenditure in major regions and/or countries is also spurring the growth of the global poultry vaccine market during the forecast period. There have been collaborative strategic initiatives and programs to help promote the adoption of poultry vaccines, thereby driving the overall global poultry vaccine market growth. Technological advancements for the manufacturing of new vaccines coupled with increasing investments in research and development by global market players will continue to fuel the growth of the global poultry vaccine market during the next five years.

The global poultry vaccine market has been segmented as disease type, product geography. By disease type, the global poultry vaccine market has been classified as avian influenza, Marek’s Disease, bronchitis, and others. The global poultry vaccine market has further been segmented by product as inactivated vaccines, attenuated live vaccines, recombinant vaccines, and others.

By geography, North America holds a significant share in the global poultry vaccine market

By geography, the global poultry vaccine market is classified into five major regional markets- North America, South America, Europe, Middle East and Africa (MEA), and Asia Pacific (APAC). North America accounted for a significant share in the global poultry vaccine market in 2019. Increasing consumption of poultry-related food products has boosted poultry production in the region. According to the United Nation Food and Agriculture Organization (FAO), the United States is the largest producer of poultry meat in the world, holding 18.0 percent of the global output. As per statistics of the Government of Canada, Canadian chicken production generated $2.8 billion in 2019, contributing 4.3 percent of cash receipts to farming operations. As of 2019, the country has 2,821 regulated chicken producers, along with nearly 4,756 commercial poultry and egg producers. High concerns about the safety of poultry food products due to the rising incidence of avain diseases are augmenting the demand for poultry vaccines in the region. Moreover, the presence of global market players in the region also contributes to the growth of poultry vaccines. The European poultry vaccine market is anticipated to witness a noteworthy compound annual growth rate during the forecast period on account of high investments in R&D and strict regulations regarding animal husbandry practices. According to the European Commission’s report “Short-Term Outlook for EU agricultural markets in 2019 and 2020”, EU’s poultry production is projected to rise by a further 2.5 percent in 2019 due to good demand and high prices. Asia Pacific (APAC) regional poultry vaccine market is also projected to grow at a noteworthy CAGR between 2019 and 2025 on account of growing poultry production in countries like China and India coupled with increasing awareness about various poultry diseases. Governments are conducting various poultry health awareness programs. Moreover, market players are expanding their reach in this region in order to capture a larger share in the global poultry vaccine market, thereby driving the market growth.   

Recent Developments

  • October 2020: Boehringer Ingelheim Animal Health launched VAXXITEK®HVT+IBD+ILT, an innovative poultry vaccine. This vaccine is first-of-its-kind which can protect poultry from three diseases- Marek’s Disease, Infectious Laryngotracheitis, and Infectious Bursal Disease.
  • April 2020: CEVA Animal Health Inc. is planning to build a new chicken vaccine manufacturing facility just north of the Guelph auto mall (Canada).
  • April 2020:Kemin Industries and Pacific GeneTech signed an exclusive agreement to commercialize a poultry salmonella vaccine. The vaccine can be administered both orally or injection in both live and inactivated forms. The partnership will focus to register the vaccine first in the European Union, and then in the U.S., Southeast Asia, and Africa.
  • April 2019: Animal health startup Applied LifeSciences & Systems (ALSS) closed an $8 million Series A round of equity financing, co-led by Mountain Grou Partners and Merck Animal Health. The amount will be used for new chick vaccination technology that will cut down on antibiotics in poultry.
  • March 2019: Merck Animal Health, a subsidiary of Merck & C., launched INNOVAX ND-ILT, poultry vaccine that provides protection against three highly infectious diseases in poultry- Marek’s Disease, Newcastle disease (ND), and Infectious Laryngotracheitis. The vaccine marked the first first vaccine available in the United States which was effective against these three highly contagious infections with a single vaccination.
  • November 2018:Merck Animal Health, a subsidiary of Merck & Co., launched INNOVAX-ND-IBD, the first live vaccine in the United States, that protects poultry from three highly infectious diseases- Marek’s Disease, Newcastle Disease (ND), and Infectious Bursal Disease (IBD).

Market Players and Competitive Intelligence

Prominent key market players in the global poultry vaccine market include Zoetis, Boehringer Ingelheim, Ceva, Merck Animal Health, a subsidiary of Merck & Co., Inc., AniCon Labor GmbH, Hester Biosciences Limited, Elanco, Biovac, Phibro Animal Health Corporation, Salfarm Danmark A/S, and AniCon Labor GmbH. These companies hold a noteworthy share in the market on account of their good brand image and product offerings. Major players in the global poultry vaccine market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last two years.

Global Poultry Vaccine Market Scope:

Report Metric Details
 Market size value in 2019  US$2,129.134 million
 Growth Rate  CAGR of during the forecast period
 Base year  2019
 Forecast period  2020–2025
 Forecast Unit (Value)  USD Million
 Segments covered  Disease Type, Product, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered Zoetis, Boehringer Ingelheim, Ceva, Merck Animal Health, a subsidiary of Merck & Co., Inc., AniCon Labor GmbH, Hester Biosciences Limited, Elanco, Biovac, Phibro Animal Health Corporation, Salfarm Danmark A/S, AniCon Labor GmbH
 Customization scope  Free report customization with purchase

 

Segmentation

  • By Disease Type
    • Avian Influenza
    • Marek’s Disease
    • Bronchitis
    • Others
  • By  Product
    • Inactivated Vaccines
    • Attentuated Live Vaccines
    • Recombinant Vaccines
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Others
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Others

Frequently Asked Questions (FAQs)

Q1. What is the size of the global poultry vaccine market?
A1. The global poultry vaccine market was valued at US$2,129.134 million in 2019.


Q2. Who are the major players in the poultry vaccine market?
A2. Prominent key market players in the global poultry vaccine market include Zoetis, Boehringer Ingelheim, Ceva, Merck Animal Health, a subsidiary of Merck & Co., Inc., AniCon Labor GmbH, Hester Biosciences Limited, among others.


Q3. How is the global poultry vaccine market segmented?
A3. The poultry vaccine market has been segmented by disease type, product, and geography.


Q4. What factors are anticipated to drive the poultry vaccine market growth?
A4. The poultry vaccine market growth is primarily attributed to the rapidly growing poultry production across the globe coupled with the growing incidence of a number of diseases among poultry.


Q5. Which region holds the largest market share in the poultry vaccine market?
A5. North America accounted for a significant share in the global poultry vaccine market owing to the increasing consumption of poultry-related food products has boosted poultry production in the region.

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
 
2. Research Methodology
2.1. Research Data
2.2. Assumptions
 
3. Executive Summary
3.1. Research Highlights
 
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
 
5. Global Poultry vaccine Market Analysis, By Disease Type
5.1. Introduction
5.2. Avian Influenza
5.3. Marek’s Disease
5.4. Bronchitis
5.5. Others
 
6. Global Poultry vaccine Market Analysis, By Product
6.1. Introduction
6.2. Inactivated Vaccines
6.3. Attentuated Live Vaccines
6.4. Recombinant Vaccines
6.5. Others
 
7. Global Poultry vaccine Market Analysis, By Geography
7.1. Introduction
7.2. North America
7.2.1. North America Poultry vaccine Market, By Disease Type, 2020 to 2025
7.2.2. North America Poultry vaccine Market, By Product, 2020 to 2025
7.2.3. By Country
7.2.3.1. USA
7.2.3.2. Canada
7.2.3.3. Mexico
7.3. South America
7.3.1. South America poultry vaccine Market, By Disease Type, 2020 to 2025
7.3.2. South America poultry vaccine Market, By Product, 2020 to 2025
7.3.3. By Country
7.3.3.1. Brazil
7.3.3.2. Argentina
7.3.3.3. Others
7.4. Europe
7.4.1. Europe poultry vaccine Market, By Disease Type, 2020 to 2025
7.4.2. Europe poultry vaccine Market, By Product, 2020 to 2025
7.4.3. By Country
7.4.3.1. Germany
7.4.3.2. France
7.4.3.3. United Kingdom
7.4.3.4. Spain
7.4.3.5. Others
7.5. Middle East and Africa
7.5.1. Middle East and Africa poultry vaccine Market, By Disease Type, 2020 to 2025
7.5.2. Middle East and Africa poultry vaccine Market, By Product, 2020 to 2025
7.5.3. By Country
7.5.3.1. Saudi Arabia
7.5.3.2. UAE
7.5.3.3. South Africa
7.5.3.4. Others
7.6. Asia Pacific
7.6.1. Asia Pacific poultry vaccine Market, By Disease Type, 2020 to 2025
7.6.2. Asia Pacific poultry vaccine Market, By Product, 2020 to 2025
7.6.3. By Country
7.6.3.1. China
7.6.3.2. Japan
7.6.3.3. India
7.6.3.4. South Korea
7.6.3.5. Australia
7.6.3.6. Others
 
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
 
9. Company Profiles 
9.1. Zoetis
9.2. Boehringer Ingelheim
9.3. Ceva
9.4. Merck Animal Health, a subsidiary of Merck & Co., Inc.
9.5. AniCon Labor GmbH
9.6. Hester Biosciences Limited
9.7. Elanco
9.8. Biovac
9.9. Phibro Animal Health Corporation
9.10. Salfarm Danmark A/S
9.11. AniCon Labor GmbH

Zoetis

Boehringer Ingelheim

Ceva

Merck Animal Health, a subsidiary of Merck & Co., Inc.

AniCon Labor GmbH

Hester Biosciences Limited

Elanco

Biovac

Phibro Animal Health Corporation

Salfarm Danmark A/S

AniCon Labor GmbH

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us